Market Closed -
Bombay S.E.
06:00:54 2024-06-28 EDT
|
5-day change
|
1st Jan Change
|
424.2
INR
|
+0.12%
|
|
-1.28%
|
-1.37%
|
Fiscal Period: March |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
2027
|
---|
Capitalization
1 |
34,726
|
194,250
|
317,096
|
157,798
|
211,463
|
228,900
|
-
|
-
|
Enterprise Value (EV)
1 |
44,264
|
208,321
|
333,657
|
177,033
|
235,117
|
251,041
|
250,591
|
248,564
|
P/E ratio
|
13.6
x
|
19.8
x
|
38.4
x
|
20
x
|
132
x
|
55.3
x
|
33
x
|
26.2
x
|
Yield
|
0.77%
|
0.55%
|
0.34%
|
0.68%
|
0.51%
|
0.34%
|
0.42%
|
0.45%
|
Capitalization / Revenue
|
1.23
x
|
4.04
x
|
6.42
x
|
2.61
x
|
4.2
x
|
3.89
x
|
3.35
x
|
3.09
x
|
EV / Revenue
|
1.56
x
|
4.33
x
|
6.76
x
|
2.93
x
|
4.66
x
|
4.26
x
|
3.67
x
|
3.35
x
|
EV / EBITDA
|
7.84
x
|
13.4
x
|
23.5
x
|
11.1
x
|
30.2
x
|
21.9
x
|
16.1
x
|
13.9
x
|
EV / FCF
|
35.3
x
|
424
x
|
974
x
|
4,733
x
|
-1,863
x
|
68.7
x
|
105
x
|
49.7
x
|
FCF Yield
|
2.83%
|
0.24%
|
0.1%
|
0.02%
|
-0.05%
|
1.45%
|
0.96%
|
2.01%
|
Price to Book
|
1.96
x
|
15
x
|
9.49
x
|
3.91
x
|
5.16
x
|
5.03
x
|
4.4
x
|
3.79
x
|
Nbr of stocks (in thousands)
|
534,572
|
536,602
|
537,359
|
538,651
|
538,966
|
539,159
|
-
|
-
|
Reference price
2 |
64.96
|
362.0
|
590.1
|
293.0
|
392.4
|
424.6
|
424.6
|
424.6
|
Announcement Date
|
20-04-30
|
21-04-29
|
22-04-28
|
23-04-27
|
24-04-25
|
-
|
-
|
-
|
Fiscal Period: March |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
2027
|
---|
Net sales
1 |
28,317
|
48,135
|
49,356
|
60,406
|
50,408
|
58,887
|
68,285
|
74,100
|
EBITDA
1 |
5,645
|
15,507
|
14,224
|
15,922
|
7,775
|
11,454
|
15,558
|
17,839
|
EBIT
1 |
3,773
|
13,456
|
11,709
|
12,681
|
3,929
|
7,169
|
10,961
|
12,366
|
Operating Margin
|
13.32%
|
27.95%
|
23.72%
|
20.99%
|
7.79%
|
12.17%
|
16.05%
|
16.69%
|
Earnings before Tax (EBT)
1 |
2,936
|
13,011
|
10,838
|
11,089
|
2,364
|
5,897
|
9,833
|
11,871
|
Net income
1 |
2,553
|
9,836
|
8,275
|
7,901
|
1,606
|
4,315
|
7,231
|
8,818
|
Net margin
|
9.01%
|
20.43%
|
16.77%
|
13.08%
|
3.18%
|
7.33%
|
10.59%
|
11.9%
|
EPS
2 |
4.786
|
18.28
|
15.35
|
14.64
|
2.970
|
7.680
|
12.87
|
16.22
|
Free Cash Flow
1 |
1,254
|
491.2
|
342.6
|
37.4
|
-126.2
|
3,653
|
2,397
|
5,000
|
FCF margin
|
4.43%
|
1.02%
|
0.69%
|
0.06%
|
-0.25%
|
6.2%
|
3.51%
|
6.75%
|
FCF Conversion (EBITDA)
|
22.21%
|
3.17%
|
2.41%
|
0.23%
|
-
|
31.89%
|
15.41%
|
28.03%
|
FCF Conversion (Net income)
|
49.12%
|
4.99%
|
4.14%
|
0.47%
|
-
|
84.66%
|
33.15%
|
56.7%
|
Dividend per Share
2 |
0.5000
|
2.000
|
2.000
|
2.000
|
2.000
|
1.450
|
1.767
|
1.900
|
Announcement Date
|
20-04-30
|
21-04-29
|
22-04-28
|
23-04-27
|
24-04-25
|
-
|
-
|
-
|
Fiscal Period: March |
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
2025 Q3
|
2025 Q4
|
---|
Net sales
1 |
10,288
|
14,248
|
15,389
|
15,759
|
15,448
|
13,809
|
11,818
|
12,244
|
11,949
|
14,397
|
13,502
|
13,870
|
13,939
|
15,122
|
EBITDA
|
2,853
|
3,967
|
4,542
|
4,489
|
4,036
|
2,855
|
1,667
|
1,879
|
1,814
|
2,415
|
-
|
-
|
-
|
-
|
EBIT
1 |
2,213
|
3,310
|
3,834
|
3,671
|
3,191
|
1,985
|
761.7
|
945
|
830.1
|
1,392
|
1,418
|
1,491
|
1,429
|
1,852
|
Operating Margin
|
21.51%
|
23.23%
|
24.91%
|
23.29%
|
20.66%
|
14.38%
|
6.45%
|
7.72%
|
6.95%
|
9.67%
|
10.5%
|
10.75%
|
10.25%
|
12.25%
|
Earnings before Tax (EBT)
|
2,035
|
3,017
|
3,559
|
3,281
|
2,778
|
1,471
|
405.8
|
538.9
|
346.2
|
1,073
|
-
|
-
|
-
|
-
|
Net income
|
1,550
|
2,305
|
2,513
|
2,328
|
2,030
|
1,030
|
248.5
|
369.5
|
231.4
|
756.1
|
-
|
-
|
-
|
-
|
Net margin
|
15.06%
|
16.18%
|
16.33%
|
14.77%
|
13.14%
|
7.46%
|
2.1%
|
3.02%
|
1.94%
|
5.25%
|
-
|
-
|
-
|
-
|
EPS
|
2.850
|
4.280
|
4.660
|
4.320
|
3.760
|
1.900
|
0.4600
|
0.6800
|
0.4300
|
1.400
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
22-01-27
|
22-04-28
|
22-07-27
|
22-10-21
|
23-01-30
|
23-04-27
|
23-07-27
|
23-10-20
|
24-01-24
|
24-04-25
|
-
|
-
|
-
|
-
|
Fiscal Period: March |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
2027
|
---|
Net Debt
1 |
9,538
|
14,071
|
16,561
|
19,235
|
23,654
|
22,141
|
21,691
|
19,664
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.69
x
|
0.9074
x
|
1.164
x
|
1.208
x
|
3.042
x
|
1.933
x
|
1.394
x
|
1.102
x
|
Free Cash Flow
1 |
1,254
|
491
|
343
|
37.4
|
-126
|
3,653
|
2,397
|
5,000
|
ROE (net income / shareholders' equity)
|
15.3%
|
45%
|
27.8%
|
21.4%
|
3.94%
|
9.72%
|
14.7%
|
15.2%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
13%
|
10.8%
|
2%
|
5%
|
8%
|
10%
|
Assets
1 |
-
|
-
|
63,594
|
73,142
|
80,239
|
86,291
|
90,386
|
88,182
|
Book Value Per Share
2 |
33.10
|
24.20
|
62.20
|
75.00
|
76.00
|
84.40
|
96.40
|
112.0
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
2,220
|
6,839
|
8,768
|
9,902
|
6,783
|
7,296
|
6,966
|
7,330
|
Capex / Sales
|
7.84%
|
14.21%
|
17.77%
|
16.39%
|
13.46%
|
12.39%
|
10.2%
|
9.89%
|
Announcement Date
|
20-04-30
|
21-04-29
|
22-04-28
|
23-04-27
|
24-04-25
|
-
|
-
|
-
|
Last Close Price
424.6
INR Average target price
393.4
INR Spread / Average Target -7.34% Consensus |
1st Jan change
|
Capi.
|
---|
| +55.32% | 815B | | +44.05% | 641B | | -6.75% | 352B | | +13.56% | 314B | | +10.68% | 303B | | +16.57% | 242B | | +13.31% | 218B | | +8.48% | 168B | | -2.81% | 159B |
Other Pharmaceuticals
|